gastroparesis glp 1 agonist A 32-year-old man developed after taking tirzepatide for weight loss, which isn't approved in India. Doctors advise against using it without medical supervision GLP-1 Gastroparesis: Hidden Dangers Beyond

These medications also delay gastric emptying through neural mechanisms, increasing the risk for perioperative aspiration during anaesthesia and sedation

Introduction Significant reductions in cardiovascular events, all-cause mortality, and the advancement of kidney disease are demonstrated by important studies such as FLOW

GLP-1 Data Survey 2025: GLP-1 Weight Loss, Types of GLP-1 Used, GLP-1 Duration Usage, GLP-1 Side Effects, Satisfaction & more.

Mean TTR decreased by 2.1% (95% CI, -3.7% to -0.6%

Evaluating what the research shows about GLP-1 medications and depression and suicidal ideation.

Our licensed providers create custom treatment plans based on your unique goals and health history, with ongoing telehealth support every step of the way